MAVIS Hub Edition 132
Published 14 November 2024
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/mavis-hub-edition-132/mavis-hub-edition-132
1. Product News
Urgent and clinically significant safety updates for veterinary medicines - 14 October 2024
Arthramid Vet – Adverse events - 14 October 2024
Prednicare 1 mg Tablets - Product recall alert - 24 September 2024
Secretary of State permits the use of 3 BTV-3 vaccines subject to licence - 10 September 2024
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK - 4 September 2024
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK - 4 September 2024
Summary of product characteristics for Bultavo-3 BTV-3 vaccine in the UK - 4 September 2024
Milprazon Chewable 12.5 mg/125 mg Film-coated Tablets for Dogs Weighing at Least 5 kg - recall - 9 August 2024
Senvelgo 15 mg/ml oral solution for cats – Safety update - 8 August 2024
| Ronidazole Capsules - Product defect recall alert - 2 August 2024 |
2. Enforcement
Illegal animal medicines: seizures, improvement notices and prosecutions - 17 September 2024
3. AMR (Antimicrobial Resistance)
Antimicrobial resistance (AMR) - 15 October 2024
4. Guidance Updates
Bluetongue serotype 3 (BTV-3) vaccination - 18 October 2024
General licence for bluetongue serotype 3 (BTV-3) vaccine - 18 October 2024
Bluetongue serotype 3 vaccine advice for veterinarians - 11 October 2024
Guidelines and guidance on the responsible use of veterinary medicines - 8 October 2024
Report a product defect: veterinary medicine - 25 September 2024
Bluetongue serotype 3 (BTV-3) vaccination - 16 September 2024
Apply for veterinary medicine wholesale dealer’s authorisation (WDA) - 16 September 2024
Advertise veterinary medicines legally - 16 September 2024
Apply for Specific Manufacturing Authorisation - 9 September 2024
Schedule 6 registration now open - 2 September 2024
Exemption from authorisation for medicines for small pet animals - 2 September 2024
Published response to the public consultation on residues surveillance charges - 28 August 2024
Pharmacovigilance of Veterinary Medicinal Products in Great Britain - 22 August 2024
Implementation explainer: Pharmacovigilance - 22 August 2024
Benefit-risk report (BRR) and signal notification submissions - 22 August 2024
Product Information Templates for Veterinary Medicines (SPC and QRD Text) - 7 August 2024
Maximum Residues Limits (MRL) - 1 August 2024
5. Surveillance
Veterinary Antimicrobial Resistance and Sales Surveillance 2022 - 24 October 2024
Residues of veterinary medicines in food: 2024 - 11 October 2024
Published response to the public consultation on residues surveillance charges - 28 August 2024
National Residues Control Programme: revision of charges - 27 August 2024
6. Statistics
Top Ten Imported Veterinary Medicines Quarterly Report 1 July to 30 September 2024 - 16 October 2024
VMD Published Standards 2024 to 2025: Monitoring performance - 11 October 2024
7. Corporate News
Authorisation application deadlines for Christmas period 2024 - 21 October 2024
Veterinary Medicines Directorate – Our governance - 21 October 2024
Change to approach for mock-ups for VMD assessment - 25 September 2024
Animal Sentience Committee’s assessment of the Veterinary Medicines Regulations (2013) revisions. - 12 September 2024
Secretary of State has permitted the use of three bluetongue vaccines subject to licence - 5 September 2024
Defra privacy notice: National Fraud Initiative - 22 August 2024
VMD FOI requests received 1 January to 30 June 2024 - 20 August 2024
VMD FOI requests received 1 July to 31 December 2023 - 19 August 2024